• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为临床试验设计增添灵活性:基于实例的适应性设计实际应用指南。

Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.

机构信息

Department of Mathematics and Statistics, Lancaster University, Fylde College, Lancaster, LA1 4YF, UK.

Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, UK.

出版信息

BMC Med. 2020 Nov 19;18(1):352. doi: 10.1186/s12916-020-01808-2.

DOI:10.1186/s12916-020-01808-2
PMID:33208155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7677786/
Abstract

Adaptive designs for clinical trials permit alterations to a study in response to accumulating data in order to make trials more flexible, ethical, and efficient. These benefits are achieved while preserving the integrity and validity of the trial, through the pre-specification and proper adjustment for the possible alterations during the course of the trial. Despite much research in the statistical literature highlighting the potential advantages of adaptive designs over traditional fixed designs, the uptake of such methods in clinical research has been slow. One major reason for this is that different adaptations to trial designs, as well as their advantages and limitations, remain unfamiliar to large parts of the clinical community. The aim of this paper is to clarify where adaptive designs can be used to address specific questions of scientific interest; we introduce the main features of adaptive designs and commonly used terminology, highlighting their utility and pitfalls, and illustrate their use through case studies of adaptive trials ranging from early-phase dose escalation to confirmatory phase III studies.

摘要

临床试验中的适应性设计允许根据累积数据对研究进行调整,从而使试验更加灵活、符合伦理道德且高效。这些好处是通过在试验过程中预先规定和适当调整可能的改变来实现的,同时保持试验的完整性和有效性。尽管统计文献中有大量研究强调了适应性设计相对于传统固定设计的潜在优势,但这些方法在临床研究中的应用仍然缓慢。造成这种情况的一个主要原因是,临床试验设计的不同适应性及其优缺点对于临床界的很大一部分人来说仍然不熟悉。本文的目的是阐明适应性设计可以用于解决哪些特定的科学问题;我们介绍了适应性设计的主要特点和常用术语,强调了它们的实用性和陷阱,并通过从早期阶段剂量递增到确证性 III 期研究的适应性试验的案例研究来说明它们的用途。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/22080d23055b/12916_2020_1808_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/70f1aaf32559/12916_2020_1808_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/a44692ee691f/12916_2020_1808_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/b11f4251679a/12916_2020_1808_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/5462b37bdd99/12916_2020_1808_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/22080d23055b/12916_2020_1808_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/70f1aaf32559/12916_2020_1808_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/a44692ee691f/12916_2020_1808_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/b11f4251679a/12916_2020_1808_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/5462b37bdd99/12916_2020_1808_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ee6/7677786/22080d23055b/12916_2020_1808_Fig5_HTML.jpg

相似文献

1
Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.为临床试验设计增添灵活性:基于实例的适应性设计实际应用指南。
BMC Med. 2020 Nov 19;18(1):352. doi: 10.1186/s12916-020-01808-2.
2
Adaptive designs in clinical trials: why use them, and how to run and report them.临床试验中的适应性设计:为何使用它们,以及如何实施和报告它们。
BMC Med. 2018 Feb 28;16(1):29. doi: 10.1186/s12916-018-1017-7.
3
Adaptive designs in clinical trials: from scientific advice to marketing authorisation to the European Medicine Agency.临床试验中的适应性设计:从向欧洲药品管理局寻求科学建议到获得上市许可
Trials. 2018 Nov 20;19(1):642. doi: 10.1186/s13063-018-3012-x.
4
Adaptive designs in clinical trials: a systematic review-part I.临床试验中的适应性设计:系统评价——第一部分。
BMC Med Res Methodol. 2024 Oct 4;24(1):229. doi: 10.1186/s12874-024-02272-9.
5
Paradigms for adaptive statistical information designs: practical experiences and strategies.适应性统计信息设计的范例:实践经验与策略。
Stat Med. 2012 Nov 10;31(25):3011-23. doi: 10.1002/sim.5410. Epub 2012 Aug 24.
6
Multi-arm multi-stage (MAMS) randomised selection designs: impact of treatment selection rules on the operating characteristics.多臂多阶段(MAMS)随机选择设计:治疗选择规则对操作特性的影响。
BMC Med Res Methodol. 2024 Jun 3;24(1):124. doi: 10.1186/s12874-024-02247-w.
7
Adaptive designs for pivotal trials: discussion points from the PSI Adaptive Design Expert Group.关键试验的适应性设计:PSI适应性设计专家组的讨论要点
Pharm Stat. 2006 Jan-Mar;5(1):61-6. doi: 10.1002/pst.206.
8
Comparison of multi-arm multi-stage design and adaptive randomization in platform clinical trials.平台临床试验中多臂多阶段设计与适应性随机化的比较。
Contemp Clin Trials. 2017 Mar;54:48-59. doi: 10.1016/j.cct.2017.01.003. Epub 2017 Jan 13.
9
Adaptive Design: A Review of the Technical, Statistical, and Regulatory Aspects of Implementation in a Clinical Trial.适应性设计:临床试验实施的技术、统计和监管方面的综述。
Ther Innov Regul Sci. 2020 Jan;54(1):246-258. doi: 10.1007/s43441-019-00052-y. Epub 2020 Jan 6.
10
Adaptive clinical trials and master protocols.适应性临床试验和主方案。
Handb Clin Neurol. 2023;193:313-323. doi: 10.1016/B978-0-323-85555-6.00005-9.

引用本文的文献

1
Bibliometric Analysis of Research Trends Related to the Publication of Clinical Trials on the Treatment of Temporomandibular Disorders Between 1973 and 2023.1973年至2023年间颞下颌关节紊乱病治疗临床试验发表相关研究趋势的文献计量分析
Int J Dent. 2025 Aug 6;2025:8594730. doi: 10.1155/ijod/8594730. eCollection 2025.
2
Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical Guidance.适应性试验设计的置信区间II:案例研究与实践指南。
Stat Med. 2025 Aug;44(18-19):e70202. doi: 10.1002/sim.70202.
3
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.

本文引用的文献

1
Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19.针对COVID-19干预措施临床试验的高效自适应设计
Stat Biopharm Res. 2020 Jul 29;12(4):483-497. doi: 10.1080/19466315.2020.1790415.
2
The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.适应性设计 CONSORT 扩展(ACE)声明:一份带有解释和说明指南的清单,用于报告使用适应性设计的随机试验。
BMJ. 2020 Jun 17;369:m115. doi: 10.1136/bmj.m115.
3
Resist the Temptation of Response-Adaptive Randomization.
适应性试验设计的置信区间I:方法学综述
Stat Med. 2025 Aug;44(18-19):e70174. doi: 10.1002/sim.70174.
4
Evidence-Based Approaches to Quality Improvement: A Narrative Review of Integrating Bayesian Adaptive Trials Into Health Services.基于证据的质量改进方法:将贝叶斯适应性试验整合到卫生服务中的叙述性综述。
J Eval Clin Pract. 2025 Aug;31(5):e70197. doi: 10.1111/jep.70197.
5
Using circulating tumor DNA as a novel biomarker of efficacy for dose-finding designs in oncology.将循环肿瘤DNA作为肿瘤学剂量探索设计中疗效的新型生物标志物。
Stat Methods Med Res. 2025 Aug;34(8):1665-1683. doi: 10.1177/09622802251350457. Epub 2025 Jul 1.
6
Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape.临床视角下的纳米颗粒疗法:分类、上市产品及监管格局
Small. 2025 Jun 2:e2502315. doi: 10.1002/smll.202502315.
7
Clinical Trial Validity Guidance from the HTACG: Looking for Chicken Teeth.HTACG的临床试验有效性指南:缘木求鱼。
J Mark Access Health Policy. 2025 Apr 16;13(2):15. doi: 10.3390/jmahp13020015. eCollection 2025 Jun.
8
Navigating challenges in pediatric trial conduct: integrating bayesian sequential design with semiparametric elicitation for handling primary and secondary endpoints.应对儿科试验实施中的挑战:将贝叶斯序贯设计与半参数诱导相结合以处理主要和次要终点
BMC Med Res Methodol. 2025 Mar 31;25(1):82. doi: 10.1186/s12874-025-02484-7.
9
The future of clinical trials of gut microbiome therapeutics in cirrhosis.肝硬化肠道微生物群疗法临床试验的未来。
JHEP Rep. 2024 Oct 10;7(1):101234. doi: 10.1016/j.jhepr.2024.101234. eCollection 2025 Jan.
10
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.胶质母细胞瘤生酮代谢疗法的临床研究框架提案
BMC Med. 2024 Dec 5;22(1):578. doi: 10.1186/s12916-024-03775-4.
抵制回应自适应随机化的诱惑。
Clin Infect Dis. 2020 Dec 31;71(11):3002-3004. doi: 10.1093/cid/ciaa334.
4
EarLy Elimination of Fatty Acids iN hypertriglyceridemia-induced acuTe pancreatitis (ELEFANT trial): Protocol of an open-label, multicenter, adaptive randomized clinical trial.高脂血症性急性胰腺炎早期脂肪酸清除(ELEFANT 试验):一项开放标签、多中心、适应性随机临床试验方案。
Pancreatology. 2020 Apr;20(3):369-376. doi: 10.1016/j.pan.2019.12.018. Epub 2019 Dec 30.
5
Improving safety of the continual reassessment method via a modified allocation rule.通过修改分配规则来提高持续评估方法的安全性。
Stat Med. 2020 Mar 30;39(7):906-922. doi: 10.1002/sim.8450. Epub 2019 Dec 20.
6
Designing and evaluating dose-escalation studies made easy: The MoDEsT web app.设计和评估递增剂量研究变得轻而易举:MoDEsT 网页应用程序。
Clin Trials. 2020 Apr;17(2):147-156. doi: 10.1177/1740774519890146. Epub 2019 Dec 19.
7
A comparison of stochastic programming methods for portfolio level decision-making.随机规划方法在投资组合决策中的比较。
J Biopharm Stat. 2020 May 3;30(3):405-429. doi: 10.1080/10543406.2019.1684307. Epub 2019 Dec 11.
8
Comparison of methods for control allocation in multiple arm studies using response adaptive randomization.使用反应适应性随机化比较多臂研究中控制分配的方法。
Clin Trials. 2020 Feb;17(1):52-60. doi: 10.1177/1740774519877836. Epub 2019 Oct 19.
9
Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.系统评价篮子试验、伞式试验和平台试验:主方案的全景分析。
Trials. 2019 Sep 18;20(1):572. doi: 10.1186/s13063-019-3664-1.
10
Adaptive platform trials: definition, design, conduct and reporting considerations.适应性平台试验:定义、设计、实施和报告考虑因素。
Nat Rev Drug Discov. 2019 Oct;18(10):797-807. doi: 10.1038/s41573-019-0034-3. Epub 2019 Aug 28.